Sionna Therapeutics, Inc. Common Stock SION Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$26.78M-31.0% | -$20.44M-0.8% | -$20.28M-12.2% | -$18.07M-9.6% | -$16.48M-4.0% | ||
| $154K+1.3% | $152K+52.0% | $100K0.0% | $100K-37.1% | $159K-4.8% | ||
| $6.55M+71.3% | $3.83M+15.7% | $3.31M+16.4% | $2.84M+35.6% | $2.09M+96.8% | ||
| $1.21M+270% | -$712K-226% | $567K+115% | -$3.83M-208% | $3.55M+228% | ||
| -$3.46M-239% | $2.49M— | —— | —— | -$4.32M-236% | ||
| -$740K-148% | $1.54M— | $0-100% | $161K-71.2% | $559K-4.1% | ||
| $489K-0.4% | $491K+0.2% | $490K0.0% | $490K-0.2% | $491K+0.2% | ||
| -$543K0.0% | -$543K-2.6% | -$529K-0.2% | -$528K0.0% | -$528K0.0% | ||
| -$21.84M-31.4% | -$16.63M-9.2% | -$15.23M+16.1% | -$18.15M-11.5% | -$16.29M-38.3% | ||
| $0-100% | $204K+134% | $87K— | $0-100% | $86K+219% | ||
| $25.33M-40.9% | $42.88M-20.8% | $54.14M-4.0% | $56.42M-67.1% | $171.6M+2,283% | ||
| $50.15M-23.6% | $65.67M-15.1% | $77.33M+133% | $33.17M+8.8% | $30.49M+35.8% | ||
| $24.82M— | —— | —— | -$23.25M+83.5% | -$141.19M— | ||
| $2.21M+33.4% | $1.66M-16.0% | $1.97M+32,800% | $6K— | $0-100% | ||
| $1.89M+14.1% | $1.66M-16.0% | $1.97M— | $0-100% | $202.39M— | ||
| $4.87M-36.1% | $7.62M-22.6% | $9.85M— | —— | $44.91M— | ||
| $200K-43.3% | $353K-57.8% | $836K-28.3% | $1.17M+67.3% | $697K-11.8% | ||
| $154K+1.3% | $152K+52.0% | $100K0.0% | $100K-37.1% | $159K-4.8% | ||
| -$543K0.0% | -$543K-2.6% | -$529K-0.2% | -$528K0.0% | -$528K0.0% | ||
| -$740K-148% | $1.54M— | $0-100% | $161K-71.2% | $559K-4.1% | ||
| $489K-0.4% | $491K+0.2% | $490K0.0% | $490K-0.2% | $491K+0.2% | ||
| $50.15M-23.6% | $65.67M-15.1% | $77.33M+133% | $33.17M+8.8% | $30.49M+35.8% | ||
| $320K— | $0— | —— | —— | $0-100% | ||
| $0— | —— | —— | —— | $202.39M— | ||
| $0— | —— | —— | —— | $330.37M— | ||
| -$543K0.0% | -$543K-2.6% | -$529K-0.2% | -$528K0.0% | -$528K0.0% | ||
| $265K— | —— | —— | —— | $318K— | ||
| $0— | —— | —— | —— | $4.27M— | ||
| $12K— | —— | —— | —— | $0— | ||
| -$21.84M-29.8% | -$16.83M-9.9% | -$15.32M+15.6% | -$18.15M-10.9% | -$16.37M-38.7% | ||
| -$21.84M-29.8% | -$16.83M-9.9% | -$15.32M+15.6% | -$18.15M-10.9% | -$16.37M-38.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Sionna Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Sionna Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.